ABL Bio Market Cap

ABL Bio has a market cap or net worth of 13.53 trillion as of January 29, 2026. Its market cap has increased by 842.17% in one year.

Market Cap

13.53T

Enterprise Value

13.45T

Revenue

88.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

245,500.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 13.53T, an increase of 2,123.62%. That is a compound annual growth rate of 54.62%.

Market Cap History

Date	Market Cap	% Change
Jan 29, 2026	13.53T	22.75%
Dec 30, 2025	11.03T	663.70%
Dec 30, 2024	1.44T	22.53%
Dec 28, 2023	1.18T	7.19%
Dec 29, 2022	1.10T	5.54%
Dec 30, 2021	1.04T	-27.59%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 19, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	82.86T
Celltrion	46.28T
ALTEOGEN	21.82T
Sam Chun Dang Pharm.	9.69T
SK Biopharmaceuticals	9.35T
HLB Co., Ltd.	8.81T
Yuhan	8.08T
LigaChem Biosciences	6.76T

Market Cap Rankings